Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou cannot use Mounjaro more than 30 days after first removing it from the fridge. Once a KwikPen is taken out of refrigerated storage and kept at room temperature, it must be used within 30 days — regardless of how many doses remain. This 30-day limit is set in the Mounjaro SmPC and exists because room-temperature conditions gradually degrade the active medicine, tirzepatide. The pen should not be used past this window even if it looks and feels unchanged. Because Mounjaro is a prescription-only treatment, questions about your specific situation (including whether a pen is still usable) are best resolved by your prescribing team before you administer any dose.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide is a biological medicine, its molecules are more sensitive to environmental conditions than a standard tablet. Refrigeration at 2–8°C keeps the active ingredient stable until the manufacturer's printed expiry date. At room temperature, slow chemical changes begin. Eli Lilly's stability testing, reflected in the licensed prescribing information, established that 30 days is the outer boundary at which the medicine still meets its quality and potency standards. After that, there is no guarantee it performs as it should. The 30-day room-temperature limit is therefore a manufacturing and regulatory ceiling, not a conservative guess.
This is why the patient information leaflet specifies both conditions: fridge from the start, and a hard 30-day clock once the pen is out. Neither instruction is optional. For full detail on temperature thresholds (there is a maximum ambient temperature as well as a time limit), the Mounjaro SmPC on the eMC is the authoritative source, our prescribers always refer patients there rather than quoting a figure that could drift out of date.
A question our prescribers hear regularly: "it's only been 32 days, can I still use it?" The honest answer is that even two days over the limit means the pen falls outside its tested, licensed window. For a closer look at what happens to Mounjaro after 30 days and why that boundary exists, we cover the detail on a dedicated page. That may feel wasteful, but administering a degraded dose does nothing helpful and could mean a missed week of treatment without your team knowing.
The real-world question is rarely abstract. It goes: "I put this pen on the fridge door, forgot it one weekend, and I'm not sure of the exact date I took it out." That uncertainty matters. If you cannot confirm the pen has been at room temperature for fewer than 30 days, treat it as expired. The risk of using a degraded pen (reduced efficacy, potentially a missed therapeutic dose) outweighs the inconvenience of replacing it.
A practical habit that many patients find useful: the moment you take a new pen from the fridge, write the date on the box in biro. That 10-second step removes all ambiguity. Storing your active pen somewhere visible in the fridge door next to everyday items also reduces the chance of accidentally leaving it out on a kitchen counter overnight.
If you are considering whether to use a Mounjaro pen that may be past its 30-day window, the answer from the prescribing guidance is clear: do not. Contact your prescriber, explain what happened, and they can advise on timing your next dose without disrupting your titration schedule.
Each Mounjaro KwikPen contains four cartridges, one per week. At the standard pace, a single pen lasts exactly four weeks, meaning a pen taken from the fridge on day one should be fully used by around day 28. The 30-day limit comfortably covers that window if you start using the pen promptly. Problems arise when a dose is missed, delayed, or when a pen is removed from the fridge well before it is needed.
There is more on the practical side of using Mounjaro beyond the 30-day mark and what steps to take when a pen may have been affected, including a guide to taking Mounjaro after 30 days if you are unsure how to proceed. For broader context on how tirzepatide works as a dual GIP and GLP-1 receptor agonist, that background can help explain why stability matters for this class of medicine specifically.
Storage integrity is one reason the NHS patient information for tirzepatide emphasises keeping pens in their original packaging until use and away from direct light and heat. These instructions work together, the 30-day rule is not the only protection; ambient temperature and light exposure also affect the pen's condition within that window.
Questions about cost, supply and what a full treatment plan looks like are covered on the weight-loss treatment overview. And if any of this raises questions specific to your current pen or your schedule, our prescribers are the right people to ask, you can start a free consultation and get a same-day clinical review from a GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.